Global Clinical Trial Imaging Market 2025–2029: Competitive Insights and Opportunities

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Market Value Is The Clinical Trial Imaging Industry Expected To Reach By 2029, Starting From 2025 Levels?

The clinical trial imaging market size has demonstrated strong expansion over recent years. It is anticipated to grow from $1.44 billion in 2024 to $1.58 billion in 2025, achieving a compound annual growth rate (CAGR) of 9.3%. This historical growth can be attributed to several factors, including heightened sales and wider distribution of clinical imaging software and services, an increasing prevalence of breast cancer risks, greater healthcare spending, the improvement of infrastructure due to rising healthcare expenditure, and increased investment in research and development by pharmaceutical and biotechnological enterprises.

The clinical trial imaging market size is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach $2.2 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 8.7%. Factors driving this growth during the forecast period include the rise in chronic diseases, increased spending on research and development, an expanding elderly demographic, a greater volume of clinical investigations, and a growing count of contract research organizations. Key trends for the forecast period encompass technological progress improving imaging techniques, strategic efforts from market participants to broaden their capacities and services, the integration of imaging-centric methods into drug development, breakthroughs in molecular imaging and AI-powered analysis, and novel product introductions.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15765&type=smp

What Are The Main Drivers Boosting The Clinical Trial Imaging Industry’s Expansion?

The expanding occurrence of chronic illnesses is anticipated to fuel the future expansion of the clinical trial imaging market. A chronic disease refers to a persistent health issue that usually necessitates continuous medical care and can restrict everyday functions or reduce life quality. This rise in chronic disease prevalence stems from exposure to environmental factors like air pollution, chemicals, and toxins, alongside shifts in lifestyle and genetic predispositions. Clinical trial imaging offers effective oversight via diagnostic images, enabling patients to better grasp their condition and the effects of therapies, thus enhancing treatment adherence and patient satisfaction. As an illustration, information from January 2023, sourced from the National Center for Biotechnology Information (NCBI), a US National Library of Medicine, indicates that by 2050, the population of individuals aged 50 years and above living with at least one chronic condition is forecast to increase by 99.5%, escalating from 71.522 million in 2020 to 142.66 million. Consequently, the growing incidence of chronic ailments is a key driver for the clinical trial imaging market.

What Are The Major Segments Identified In The Clinical Trial Imaging Market?

The clinical trial imagingmarket covered in this report is segmented –

1) By Product And Services: Services; Software

2) By Modality: Computed Tomography; Magnetic Resonance Imaging; Echocardiography; Nuclear Medicine; Positron Emission Tomography; X-Ray; Ultrasound; Optical Coherence Tomography; Other Modalities

3) By Application: Oncology; Neurology; Cardiology; Endocrinology; Dermatology; Hematology; Other Applications

4) By Distributer: Direct Sales; Tender Sales

5) By End User: Contract Research Organizations; Pharmaceutical And Biotechnology Companies; Medical Device Manufacturers; Academic And Government Research Institutes; Other End-Users

Subsegments:

1) By Services: Imaging Services For Diagnostics; Image Acquisition Services; Image Analysis Services; Image Management And Archiving Services

2) By Software: Imaging Software For Analysis; Image Processing Software; Radiology Information Systems (RIS); Picture Archiving And Communication Systems (PACS)

Which Market Trends Are Creating New Opportunities In The Clinical Trial Imaging Industry?

Major companies operating in the clinical trial imaging market are developing cloud-based image tools to provide better solutions and improve the efficiency of clinical trials. Cloud-based imaging tools refer to software applications and platforms that utilize cloud computing technology for the storage, management, and analysis of medical images. For instance, in March 2023, Clarion, a US-based manufacturer of advanced power distribution systems, introduced a cutting-edge cloud-based image viewer tool. This innovative tool enables real-time, on-demand viewing and manipulation of high-resolution images, offering read-quality access to images in near real-time while eliminating previously required manual steps. It streamlines the image viewing process, removing manual efforts and making image accessibility easy, secure, and compliant with data privacy standards. The tool provides full-resolution viewing and manipulation capabilities, empowering end users to gain valuable insights into their trial subject.

Who Are The Key Multinational Companies Dominating The Clinical Trial Imaging Market?

Major companies operating in the clinical trial imaging market are Koninklijke Philips N.V., Labcorp Drug Development, Icon Plc, PPD Inc., Syneos Health, Charles River Laboratories, Parexel International Corporation, Clario, Medpace Inc., Medidata Solution Inc., Biotelemetry Inc., WIRB-Copernicus Group, ProScan Imaging LLC, Invicro LLC, Perspectum, Radiant Sage LLC, Worldcare Clinical LLC, Intrinsic Imaging LLC, Datatrak Inc., IXICO Plc, Calyx Inc., Resonance Health Ltd., Anagram-ESIC SL

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/clinical-trial-imaging-global-market-report

How Is Clinical Trial Imaging Market Demand Varying Across Different Regions?

North America was the largest region in the clinical trial imaging market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical trial imaging market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Clinical Trial Imaging Market Report:

https://www.thebusinessresearchcompany.com/customise?id=15765&type=smp

Browse Through More Reports Similar to the Global Clinical Trial Imaging Market 2025, By The Business Research Company

Preclinical Assets Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/preclinical-assets-global-market-report

Artificial Intelligence Ai In Clinical Trials Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-clinical-trials-global-market-report

Clinical Trial Supply And Logistics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/clinical-trial-supply-and-logistics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795